Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Transl Stroke Res. 2014 Jun 17;5(5):586–594. doi: 10.1007/s12975-014-0353-y

Figure 5.

Figure 5

(A) The immunoreactivity of heme oxygenase-1 (HO-1), and complement C5b-9 and C3a in the ipsilateral periventricular area 24 hours after sham-operation or TBI with or without DFX treatment. Scale bar=50μm. (B) HO-1, (C) C5b-9 and (D) C3a protein levels in the CSF at 24 hours after sham-operation or TBI with or without DFX treatment. Values are mean ± SE, n=4 for each group, * p<0.05, # p<0.01 vs. sham group. ## p<0.01 vs. the other groups.

HHS Vulnerability Disclosure